| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/08/2004 | US6746773 Implant with coating of copolymer of vinylidenefluoride (vdf) and/or tetrafluoroethylene (tfe) with another monomer in amounts effective to reduce thrombosis and/or restenosis when such stents are used in, e.g. angioplasty procedures |
| 06/08/2004 | US6746696 Triterpene compositions and methods for use thereof |
| 06/08/2004 | US6746692 Modified release pharmaceutical formulation comprising amoxycillin |
| 06/08/2004 | US6746691 Intermediate release nicotinic acid formulation having a dissolution curve similarity fit factor of about 79, and in in vitro dissolution profile in deionized water at about 100rpm; time release agents; fda orange book listed patent for niacin and simvastatin |
| 06/08/2004 | US6746690 Process for producing composite preparation containing nucleic acid |
| 06/08/2004 | US6746689 Intradermal-penetration agents for topical local anesthetic administration |
| 06/08/2004 | US6746688 Alkyl-ester of levodopa in solvent |
| 06/08/2004 | US6746678 Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments |
| 06/08/2004 | US6746677 For preventing and controlling helminthiasis, infection by acarids and arthropod endo-and ectoparasites and bacterial and viral disease in warm-blooded animals |
| 06/08/2004 | US6746673 For prophylaxis and/or treatment of an autoimmune disease or rheumatoid arthritis |
| 06/08/2004 | US6746666 Micropigment mixture |
| 06/08/2004 | CA2307552C Substituted pyridine compounds as anti-inflammatory agents |
| 06/08/2004 | CA2233219C Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration |
| 06/08/2004 | CA2225597C Use of a organopolysiloxane as a perfume fixative and/or for prolonging its release |
| 06/08/2004 | CA2201358C Pharmaceutical composition |
| 06/08/2004 | CA2133741C Photochemotherapeutic method using 5-aminolevulinic acid and precursor thereof |
| 06/08/2004 | CA2132528C Agent for use as an anti-irritant |
| 06/08/2004 | CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 06/08/2004 | CA2100256C A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose |
| 06/08/2004 | CA2091002C Taxane derivatives, their preparation and use in oncology |
| 06/08/2004 | CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 06/03/2004 | WO2004046356A1 EXON 1β OF PDGF RECEPTOR α GENE AND UTILIZATION THEREOF |
| 06/03/2004 | WO2004046334A2 Antioxidant and antimicrobial agents and methods of use thereof |
| 06/03/2004 | WO2004046331A2 2’-branched nucleosides and flaviviridae mutation |
| 06/03/2004 | WO2004046320A2 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/03/2004 | WO2004046223A2 Polyionene polymers with hydrolyzable linkages |
| 06/03/2004 | WO2004046211A1 Polymeric boronic acid derivatives as lipase inhibitors |
| 06/03/2004 | WO2004046196A2 Compositions and methods for treating bacterial infections with protein-dalbavancin complexes |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046160A2 Amino-lna, thio-lna and alpha-l-oxy-ln |
| 06/03/2004 | WO2004046159A1 Antiviral nucleoside derivatives |
| 06/03/2004 | WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 06/03/2004 | WO2004046143A1 Substituted indolepyridinium as anti-infective compounds |
| 06/03/2004 | WO2004046135A1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 06/03/2004 | WO2004046132A1 4-tetrazolyl-4phenylpiperidine derivatives for treating pain |
| 06/03/2004 | WO2004046120A2 Diaminotriazoles useful as inhibitors of protein kinases |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046116A1 Novel process for the preparation of imidazolyl compounds |
| 06/03/2004 | WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 06/03/2004 | WO2004046111A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/03/2004 | WO2004046110A1 Antagonist to melanin-concentrating hormone receptor |
| 06/03/2004 | WO2004046109A2 Ionene oligomers and polymers |
| 06/03/2004 | WO2004046104A2 Treatment of lung cells with histone deacetylase inhibitors |
| 06/03/2004 | WO2004046103A2 Arylpyridine compounds |
| 06/03/2004 | WO2004046096A2 Novel ligands that are antagonists of raf receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/03/2004 | WO2004046089A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046084A1 Improved process for preparation of gabapentin |
| 06/03/2004 | WO2004046083A1 Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments |
| 06/03/2004 | WO2004046081A1 Beta-nitrostyrene compound and telomerase inhibitor having an anticancer activity |
| 06/03/2004 | WO2004046070A2 Modulation of proteins by phenolic compoudns |
| 06/03/2004 | WO2004046068A2 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/03/2004 | WO2004045718A2 Treatment of cognitive dysfunctions' |
| 06/03/2004 | WO2004045679A1 Peritoneal dialysis method |
| 06/03/2004 | WO2004045647A1 Amplification of biotin-mediated targeting |
| 06/03/2004 | WO2004045646A1 Pharmaceutical compositions having a modified vehicle |
| 06/03/2004 | WO2004045644A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND β-BLOCKER |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045637A1 Dalbavancin compositions for treatment of bacterial infections |
| 06/03/2004 | WO2004045636A1 Methods of administering dalbavancin for treatment of bacterial infections |
| 06/03/2004 | WO2004045635A1 Muslce building preparation |
| 06/03/2004 | WO2004045629A1 Polyionenes for treating infections associated with cystic fibrosis |
| 06/03/2004 | WO2004045628A1 Platelet aggregation inhibitor comprising anhydrofructose and its derivative |
| 06/03/2004 | WO2004045627A1 A3ar agonists for the treatment of inflammatory arthritis |
| 06/03/2004 | WO2004045626A1 Nadh/nadph-containing compound |
| 06/03/2004 | WO2004045624A1 Medicinal composition |
| 06/03/2004 | WO2004045623A1 Inositolized phospholipids |
| 06/03/2004 | WO2004045622A1 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations |
| 06/03/2004 | WO2004045621A1 Process to minimize loss through adhesion to equipment surfaces |
| 06/03/2004 | WO2004045620A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| 06/03/2004 | WO2004045619A1 Freeze-dried lecithin nanometer powder injection of ursolic acid and it's preparation method |
| 06/03/2004 | WO2004045618A2 Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 06/03/2004 | WO2004045617A1 Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer |
| 06/03/2004 | WO2004045615A1 Palonosetron for the treatment of chemotherapy-induced emesis |
| 06/03/2004 | WO2004045613A2 Use of domperidone for reducing fertility in mammalian females |
| 06/03/2004 | WO2004045612A1 Use of a proton pump inhibitor for preventing postoperative nausea and vomiting |
| 06/03/2004 | WO2004045611A1 Use of a thiazolidinedione for the reduction of side effects of chemotherapy |
| 06/03/2004 | WO2004045609A2 Hydroxypyridinones for the local treatment of skin microcirculatory disorders |
| 06/03/2004 | WO2004045608A1 Pharmaceutical compositions containing a biguanide-glitazone combination |
| 06/03/2004 | WO2004045606A1 Treatment of gastrointestinal disorders with duloxetine |
| 06/03/2004 | WO2004045605A1 Use of flavonoid for the treatment of overweight and the reduction of the mammalian appetite |
| 06/03/2004 | WO2004045604A1 Combination of flavonoid and procyanidin for the reduction of the mammalian appetite |
| 06/03/2004 | WO2004045603A1 Medicinal composition for treating sudden deafness |
| 06/03/2004 | WO2004045602A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 06/03/2004 | WO2004045601A1 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045598A1 Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| 06/03/2004 | WO2004045597A1 Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide |
| 06/03/2004 | WO2004045596A1 Method of lowering crp and reducing systemic inflammation |
| 06/03/2004 | WO2004045595A1 USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFβ |
| 06/03/2004 | WO2004045594A1 Agent for dissolving dental calculi and dental caries |
| 06/03/2004 | WO2004045593A2 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 06/03/2004 | WO2004045592A2 Compounds and methods for increasing neurogenesis |
| 06/03/2004 | WO2004045591A2 Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events |
| 06/03/2004 | WO2004045589A1 Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders |
| 06/03/2004 | WO2004045587A1 Pharmaceutical tablets containing tibolone and a coating |
| 06/03/2004 | WO2004045584A1 Bupropion hydrochloride solid dosage forms |
| 06/03/2004 | WO2004045581A1 Veterinary antiparasite suspension injection |
| 06/03/2004 | WO2004045579A2 Pharmaceutical compositions and dosage forms of thalidomide |